AVALA RES
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.
AVALA RES (CVJ) - Total Assets
Latest total assets as of June 2024: €92.77 Million EUR
Based on the latest financial reports, AVALA RES (CVJ) holds total assets worth €92.77 Million EUR as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
AVALA RES - Total Assets Trend (2020–2024)
This chart illustrates how AVALA RES’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
AVALA RES - Asset Composition Analysis
Current Asset Composition (June 2024)
AVALA RES's total assets of €92.77 Million consist of 17.5% current assets and 82.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 1.8% |
| Accounts Receivable | €1.61 Million | 1.7% |
| Inventory | €10.19 Million | 11.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €36.00K | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how AVALA RES's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: AVALA RES's current assets represent 17.5% of total assets in 2024, an increase from 16.4% in 2020.
- Cash Position: Cash and equivalents constituted 1.8% of total assets in 2024, down from 2.0% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 11.0% of total assets.
AVALA RES Competitors by Total Assets
Key competitors of AVALA RES based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
AVALA RES - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - AVALA RES generates 0.17x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - AVALA RES is currently not profitable relative to its asset base.
AVALA RES - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.21 | 0.87 | - |
| Quick Ratio | 0.08 | 0.37 | - |
| Cash Ratio | 0.00 | 0.00 | - |
| Working Capital | €-61.98 Million | € -3.19 Million | - |
AVALA RES - Advanced Valuation Insights
This section examines the relationship between AVALA RES's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.16 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -28.3% |
| Total Assets | €92.77 Million |
| Market Capitalization | $113.22K USD |
Valuation Analysis
Below Book Valuation: The market values AVALA RES's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: AVALA RES's assets decreased by 28.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for AVALA RES (2020–2024)
The table below shows the annual total assets of AVALA RES from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | €92.77 Million | -28.34% |
| 2023-06-30 | €129.47 Million | -7.30% |
| 2022-06-30 | €139.66 Million | +37.20% |
| 2021-06-30 | €101.79 Million | +33.23% |
| 2020-06-30 | €76.40 Million | -- |